Skip to main content
PMC home page
The BMJ logoLink to The BMJ
. 1994 Feb 19;308(6927):503–506. doi: 10.1136/bmj.308.6927.503

Risk of gynaecomastia associated with cimetidine, omeprazole, and other antiulcer drugs.

L A García Rodríguez 1, H Jick 1
PMCID: PMC2542783  PMID: 8136667

Abstract

OBJECTIVE--To study the risk of gynaecomastia associated with cimetidine, misoprostol, omeprazole and ranitidine. DESIGN--Open cohort study with nested case-control analysis. SETTING--General practices in United Kingdom that had computerised offices, 1989-92. SUBJECTS--81,535 men aged 25-84 years who received at least one prescription for cimetidine, misoprostol, omeprazole, or ranitidine during the study period. MAIN OUTCOME MEASURES--New occurrences of idiopathic gynaecomastia diagnosed by general practitioner. RESULTS--The relative risk of gynaecomastia for current users of cimetidine compared with non-users was 7.2 (95% confidence interval 4.5 to 11.3). Relative risks for misoprostol, omeprazole, and ranitidine were 2.0 (0.1 to 10.7), 0.6 (0.1 to 3.3), and 1.5 (0.8 to 2.6), respectively. Current users of cimetidine on a daily dose > or = 1000 mg had more than 40 times the risk of developing gynaecomastia than non-users. The period of highest risk was seven to 12 months after starting cimetidine treatment. Spironolactone (relative risk 9.3 (3.3 to 26.1)) and verapamil (9.7 (2.6 to 36.0)) were associated with a relative risk of gynaecomastia comparable to one for cimetidine. CONCLUSIONS--Use of cimetidine, but not the three other antiulcer drugs, is associated with a substantially greater risk of gynaecomastia in men. A strong dose-response relation was present among cimetidine users.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Braunstein G. D. Gynecomastia. N Engl J Med. 1993 Feb 18;328(7):490–495. doi: 10.1056/NEJM199302183280708. [DOI] [PubMed] [Google Scholar]
  2. Carlson H. E. Gynecomastia. N Engl J Med. 1980 Oct 2;303(14):795–799. doi: 10.1056/NEJM198010023031405. [DOI] [PubMed] [Google Scholar]
  3. Convens C., Verhelst J., Mahler C. Painful gynaecomastia during omeprazole therapy. Lancet. 1991 Nov 2;338(8775):1153–1153. doi: 10.1016/0140-6736(91)92018-w. [DOI] [PubMed] [Google Scholar]
  4. Delle Fave G. F., Tamburrano G., De Magistris L., Natoli C., Santoro M. L., Carratu R., Torsoli A. Gynaecomastia with cimetidine. Lancet. 1977 Jun 18;1(8025):1319–1319. doi: 10.1016/s0140-6736(77)91358-7. [DOI] [PubMed] [Google Scholar]
  5. Galbraith R. A., Michnovicz J. J. Omeprazole fails to alter the cytochrome P450-dependent 2-hydroxylation of estradiol in male volunteers. Pharmacology. 1993 Jul;47(1):8–12. doi: 10.1159/000139072. [DOI] [PubMed] [Google Scholar]
  6. Galbraith R. A., Michnovicz J. J. The effects of cimetidine on the oxidative metabolism of estradiol. N Engl J Med. 1989 Aug 3;321(5):269–274. doi: 10.1056/NEJM198908033210501. [DOI] [PubMed] [Google Scholar]
  7. Hosmer D. W., Lemeshow S. Confidence interval estimation of interaction. Epidemiology. 1992 Sep;3(5):452–456. doi: 10.1097/00001648-199209000-00012. [DOI] [PubMed] [Google Scholar]
  8. Jensen R. T., Collen M. J., Pandol S. J., Allende H. D., Raufman J. P., Bissonnette B. M., Duncan W. C., Durgin P. L., Gillin J. C., Gardner J. D. Cimetidine-induced impotence and breast changes in patients with gastric hypersecretory states. N Engl J Med. 1983 Apr 14;308(15):883–887. doi: 10.1056/NEJM198304143081508. [DOI] [PubMed] [Google Scholar]
  9. Jick H., Jick S. S., Derby L. E. Validation of information recorded on general practitioner based computerised data resource in the United Kingdom. BMJ. 1991 Mar 30;302(6779):766–768. doi: 10.1136/bmj.302.6779.766. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Lindquist M., Edwards I. R. Endocrine adverse effects of omeprazole. BMJ. 1992 Aug 22;305(6851):451–452. doi: 10.1136/bmj.305.6851.451. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Mignon M., Vallot T., Bonfils S. Gynecomastia and histamine-2 antagonists. Lancet. 1982 Aug 28;2(8296):499–499. doi: 10.1016/s0140-6736(82)90529-3. [DOI] [PubMed] [Google Scholar]
  12. Santucci L., Farroni F., Fiorucci S., Morelli A. Gynecomastia during omeprazole therapy. N Engl J Med. 1991 Feb 28;324(9):635–635. doi: 10.1056/NEJM199102283240917. [DOI] [PubMed] [Google Scholar]
  13. Spence R. W., Celestin L. R. Gynaecomastia associated with cimetidine. Gut. 1979 Feb;20(2):154–157. doi: 10.1136/gut.20.2.154. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Tosi S., Cagnoli M. Painful gynecomastia with ranitidine. Lancet. 1982 Jul 17;2(8290):160–160. doi: 10.1016/s0140-6736(82)91128-x. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES